| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $950.8M | +19.7% |
| R&D Expense | $190.4M | +18.7% |
| SG&A Expense | $95.6M | +11.2% |
| Operating Income | $152.9M | +12.7% |
| Pre-tax Income | $161.1M | +7.2% |
| Income Tax | $20.2M | +137.6% |
| Net Income | $140.9M | -30.9% |
| EPS (Basic) | $3.91 | -30.6% |
| EPS (Diluted) | $3.88 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $107.0M | +151.7% |
| Accounts Receivable | $36.9M | +51.5% |
| Current Assets | $353.3M | +5.3% |
| Total Assets | $689.0M | +9.9% |
| Current Liabilities | $106.8M | +68.8% |
| Total Liabilities | $146.4M | +36.3% |
| Stockholders' Equity | $542.6M | +4.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $242.1M | +28.7% |
| Capital Expenditures | $3.2M | +56.5% |
| Investing Cash Flow | $10.2M | +106.8% |
| Financing Cash Flow | -$187.9M | -332.9% |
| Free Cash Flow | $238.9M | +28.4% |
| -30.1% |